An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. A health worker takes a blood sample from a woman to perform a rapid HIV test in Venezuela in 2021.
Mandatory Credit: Yuri Cortez/AFP/Getty Images
Stories this photo appears in:
HIV vaccine candidate induces immune response in early clinical trial: 'An important step forward'
An experimental HIV vaccine has been found to induce broadly neutralizing antibodies among a small group of volunteers in a Phase 1 study. The findings suggest that a two-dose regimen of the vaccine, given eight weeks apart, can elicit immune responses against the human immunodeficiency virus.
